Published: Oct 08, 2025
Updated: Oct 09, 2025

The experience of those with Parkinson's disease is frequently characterised by an unrelenting balancing act. Levodopa and other medications offer vital respite, but their efficacy eventually diminishes. "Off" periods lengthen, dyskinesias (involuntary movements) become more disruptive, and the fluctuations between mobility and rigidity grow increasingly unpredictable and disabling.
The critical question arises: When is the right time to consider Deep Brain Stimulation (DBS)? For decades, DBS was viewed as a "last resort," reserved only for advanced, medication-resistant stages. Groundbreaking research and clinical experience now tell a profoundly different story: Considering DBS earlier in the Parkinson's journey can significantly improve long-term quality of life, slow functional decline, and offer thegreatest window of opportunity to regain control. India provides a strong route to prompt, professional care for patients from abroad who want access to this life-altering procedure without incurring exorbitant expenses or delays, made possible by MediGence.
The traditional "wait until it's bad" approach to DBS is fading, thanks to compelling evidence:
1. The EARLYSTIM Trial (2013): A Landmark Revelation: This pivotal study compared DBS plus best medical therapy to best medical therapy alone in patients with early motor complications, specifically, those experiencing troublesome fluctuations and dyskinesias for less than 3 years, with a disease duration of around 7-8 years. The results were transformative:
2. Preserving Function, Not Just Rescuing It: DBS is most effective when implanted while patients still have significant motor function and cognitive reserve to benefit from it. Waiting until severe disability, significant cognitive decline, or frequent falls sets in can mean:
3. Neuroprotective Potential (Emerging Evidence): While not definitively proven as a disease-modifying therapy, some research suggests DBS might have neuroprotective effects by stabilizing dysfunctional neural circuits earlier in the disease process. More studies are ongoing, but the possibility adds weight to the "earlier is better" argument.
4. Better Tolerance & Adaptation: Younger, less frail patients typically tolerate surgery better and adapt more readily to the programming process and life with the device.
DBS isn't for everyone at diagnosis. The ideal candidate is typically someone who:
If you or your loved one experiences several of these, it's time to seriously explore DBS:
Choosing DBS earlier aligns perfectly with the advantages offered by India's world-class healthcare system and MediGence's facilitation:
1. Maximizing the Benefit Window: Accessing DBS earlier through India allows you to regain years of higher quality life sooner. MediGence streamlines the process, minimising delays between decision and treatment.
2. Unparalleled Cost-Effectiveness (Savings of 60-80%): The financial barrier to timely DBS is drastically reduced in India. Comprehensive DBS (surgery, device, hospital stay, programming) typically costs $25,000 - $40,000 USD in India. This makes early intervention financially feasible without devastating debt.
3. Access to Cutting-Edge Minimally Invasive Techniques: India's leading centres (Seven Hills Hospital, Global Health Centre, Wockhardt Hospital, Artemis Health Institute, Sterling Wockhardt Hospital, BGS Gleneagles Global Hospital, Medanta, Fortis FMRI, Jaypee Hospital, Manipal) utilise:
4. World-Class Expertise & High Volumes: Access fellowship-trained neurosurgeons and neurologists specialising in movement disorders, performing high volumes of DBS procedures. High volume correlates with better outcomes.
5. Minimal Waiting Times: Avoid year-long waits common in many public healthcare systems. MediGence can facilitate consultations and surgery often within weeks, crucial for intervening at the optimal time.
6. Comprehensive Multidisciplinary Care: Teams include neurosurgeons, neurologists, neuropsychologists, neurophysiologists, and specialised nurses, essential for thorough pre-surgical evaluation and post-operative management.
7. Robust Remote Care: Leading Indian centers offer secure telehealth platforms, allowing your local neurologist (coordinated by MediGence) to collaborate with your Indian team for long-term programming adjustments and follow-up, reducing the need for frequent international travel post-surgery.
8. Holistic Support with MediGence: Navigating DBS abroad is complex. MediGence provides:
1. Awareness & Exploration: Recognise the signs indicating it might be time. Research DBS timing. Contact MediGence for an initial consultation.
2. Pre-Qualification & Records Review: Share detailed medical history, medication list, ON/OFF diaries, and recent brain MRI with MediGence. They assess general candidacy.
3. Expert Matching & Virtual Consultation: Arrange a virtual consultation with DBS team in India to discuss your case in depth.
4. Comprehensive Pre-Surgical Evaluation (India): Travel to India (MediGence handles visa, flights, transfers, and accommodation). Undergo thorough assessments:
5. Minimally Invasive DBS Surgery: Utilising robotics and intraoperative imaging for precision. Hospital stay is typically 2-4 nights.
6. Initial Recovery & Programming in India: Stay 1-3 weeks post-discharge. Initial device activation and programming sessions begin. Gentle recovery.
7. Return Home & Long-Term Optimisation: Travel home with detailed records. Continue programming with your local neurologist, supported by remote consultations with your Indian team facilitated by MediGence. Settings are fine-tuned over months.
8. Thriving: Enjoy significantly improved symptom control, reduced medication burden, greater independence, and a vastly improved quality of life - achieved earlier in your Parkinson's journey.
Choosing DBS earlier is not about rushing; it's about strategically intervening at the point where it offers the maximum potential to preserve function, enhance quality of life, and slow the functional decline associated with Parkinson's progression. Waiting until symptoms are severe often means settling for less improvement and facing higher risks.
India, with its combination of world-class DBS expertise, cutting-edge minimally invasive technology, unparalleled affordability, and minimal waiting times - all seamlessly facilitated by MediGence, provides an accessible and optimal pathway to access this transformative therapy at the right time.
If you recognise the signs of medication-refractory motor fluctuations or dyskinesias impacting your life, don't resign yourself to years of decline. Explore the possibility of timely DBS. Contact MediGence today for a free, confidential consultation. Let us help you determine if now is your best time to reclaim stability, independence, and hope.
Seize the moment. Your best life with Parkinson's may start sooner than you think.

Miss Nimra Haseeb is a medical researcher and a scientific content writer. She holds a Bachelor’s degree in Biotechnology and a Master’s in Biochemistry from Integral University, Lucknow. With strong experience in healthcare research, she specializes in secondary research, clinical data analysis, and evidence-based medical writing. Her work focuses on transforming complex scientific and medical information into clear, accurate, and reliable healthcare content for patients and healthcare audiences. She is also experienced in interpreting medical studies and healthcare trends to deliver well-researched and informative content that supports better health awareness and decision-making.

Amit Bansal is a serial entrepreneur, Co-Founder, and CEO of MediGence. He has more than 17 years of strong technology experience. Having worked for some of the recognized companies in India, Australia and traveled worldwide to help businesses to grow multi-folded under his leadership and strategic guidance.





Delhi, India

Istanbul, Turkey

Istanbul, Turkey

Istanbul, Turkey